Follow The Filings

ICUI ICU Medical

ICU Medical earnings company data as of 11:42 AM ET 11/17

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 2.15 — —
Rev $554.0M $560.4M Beat +1.2%

Insider trades

Open-market buys and sales by ICUI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ICUI insider trades
  • None no insider bought on the open market
  • $4.9M sold by 6 insiders outside a trading plan
  • $3.5M sold by 2 insiders under 10b5-1 plans
  1. David C. Greenberg Director
    Sale
    $156K 883 shares at $176.12 8.7% of stake
    Traded Nov 20 Filed Nov 20
  2. Elisha W. Finney Director
    Sale
    $316K 1,765 shares at $179.00 27% of stake
    Traded Nov 12–13 Filed Nov 13
  3. Virginia Ruth Sanzone VP, General Counsel
    Planned sale
    $819K 4,856 shares at $168.69 25% of stake
    Traded Sep 3 Filed Sep 3
  4. Brian Michael Bonnell CFO
    Planned sale
    $1.1M 6,381 shares at $175.00 10% of stake
    Traded Sep 1 Filed Sep 1
  5. Brian Michael Bonnell CFO
    Planned sale
    $1.6M 9,307 shares at $172.79 13% of stake
    Traded Aug 31 Filed Aug 31
  6. Daniel Woolson VP, GM-Infusion Capital
    Sale
    $982K 5,417 shares at $181.33 24% of stake
    Traded Aug 13 Filed Aug 13
  7. Ben Sousa Chief Information Officer
    Sale
    $401K 2,250 shares at $178.32 42% of stake
    Traded Aug 12 Filed Aug 12
  8. Christian B. Voigtlander COO
    Sale
    $1.6M 8,929 shares at $182.93 19% of stake
    Traded Aug 11 Filed Aug 11
  9. Elisha W. Finney Director
    Sale
    $69K 378 shares at $182.48 7.2% of stake
    Traded Aug 11 Filed Aug 11
  10. Daniel Woolson President
    Sale
    $281K 2,123 shares at $132.21 8.6% of stake
    Traded May 22 Filed May 22
  11. Virginia Ruth Sanzone VP, General Counsel
    Sale
    $304K 2,447 shares at $124.08 11% of stake
    Traded May 14 Filed May 15
  12. David C. Greenberg Director
    Sale
    $298K 2,424 shares at $122.91 23% of stake
    Traded May 12 Filed May 13
  13. Daniel Woolson VP, GM-Infusion Capital
    Sale
    $441K 2,897 shares at $152.35 20% of stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
  14. Virginia Ruth Sanzone VP, General Counsel
    Sale
    $132K 930 shares at $142.35 15% of stake
    Traded Nov 11, 2025 Filed Nov 12, 2025
  15. Elisha W. Finney Director
    Sale
    $180K 1,285 shares at $140.42 24% of stake
    Traded Nov 11, 2025 Filed Nov 12, 2025

Also filed in the last 12 months, not counted as buying or selling: 35 option exercises, 25 share withholdings for taxes, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.03,5.07,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf